Faes Farma, S.A.

Quick facts

Phase 3 pipeline

• Bilastine Ophthalmic Solution 0.6% · Ophthalmology / Allergy
  Bilastine is a selective H1-receptor antagonist that blocks histamine-mediated allergic responses in the eye.
• Vehicle of Bilastine Ophthalmic Solution · Ophthalmology / Allergy
  Bilastine is a selective H1-receptor antagonist that blocks histamine-mediated allergic responses in ocular tissues.

Phase 2 pipeline

• Bilastine 0%
• Bilastine 0.2%
• Bilastine 0.4% · Allergy
  Bilastine is an antihistamine that works by blocking the action of histamine, a substance in the body that causes allergy symptoms.
• Bilastine 0.6% · Allergy
  Bilastine is an antihistamine that works by blocking the action of histamine, a substance in the body that causes allergy symptoms.

Phase 1 pipeline

• [14C]-bilastine
• Bilastine & Ketoconazole

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Faes Farma, S.A. portfolio CI brief
• Faes Farma, S.A. pipeline updates RSS